BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - April 3, 2026

  April 5, 2026

   · 

  2 min read
• Press Releases

  Rhythm Pharmaceuticals Announces Changes to Board of Directors

  April 5, 2026

   · 

  8 min read
• Press Releases

  GenSight Biologics Confirms Definitive Full-Year 2025 Consolidated Financial Results Are in Line with Estimates

  April 5, 2026

   · 

  13 min read
• Press Releases

  Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - April 3, 2026

  April 5, 2026

   · 

  1 min read
• Press Releases

  IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 3, 2026

  April 5, 2026

   · 

  1 min read
• Press Releases

  Spyre Therapeutics Announces Grants of Inducement Awards - April 3, 2026

  April 5, 2026

   · 

  1 min read
• Press Releases

  Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)

  April 5, 2026

   · 

  7 min read
• Press Releases

  Leading Parkinson’s Organizations Urge Congress to Preserve Progress and Strengthen Parkinson’s Research Funding at the National Institutes of Health

  April 5, 2026

   · 

  4 min read
• Press Releases

  Allevion Medical™ Receives 510K Clearance for Vantage™ — A Fully Disposable Kit Featuring a Novel Approach to Spinal Decompression

  April 5, 2026

   · 

  2 min read
• Press Releases

  Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

  April 5, 2026

   · 

  5 min read